#316 To Pee or Not to Pee: Combination agents for benign prostatic hypertrophy
CLINICAL QUESTION
For patients with benign prostatic hypertrophy (BPH) is combination therapy with alpha-blockers and 5-alpha reductase inhibitors (5ARI) more efficacious than alpha-blockers alone?
BOTTOM LINE
At best, adding 5ARIs to alpha-blockers reduces the number of men with clinical progression (5% compared to 10% on alpha-blocker alone), and the number needing BPH surgery (2% compared to 8% on alpha-blocker alone). Drug related adverse effects are increased from 19% on alpha-blockers alone to 28% on combination.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
- Systematic review1 identified 6 RCTs, 2 with >1 year follow-up.2,3 Enrolled patients were symptomatic white males receiving additional testing (example transrectal ultrasound) and specialist care.2,3 Four-year outcomes reported below.
- Doxazosin (1mg titrated up to 8mg), doxazosin plus finasteride (5mg), or placebo (n=3,047):2
- Clinical progression: Composite of worsening symptoms [>4 point change on 35-point American Urological Association Score], acute retention, incontinence, or recurrent urinary tract infection (UTI). Symptom progression contributed ~80% of the composite.
- Doxazosin 10%, combination 5%: Number needed to treat (NNT)=20 (placebo 17%).
- BPH surgery:
- Doxazosin 3%, combination 1%: NNT=50 (placebo 5%).
- Adverse effects, statistics not reported:4
- Decreased erectile function: Doxazosin 13%, combination 17% (placebo 13%).
- Tamsulosin (0.4mg) or tamsulosin plus dutasteride (0.5mg) (n=4,844):3
- Clinical progression: Composite of worsening symptoms [≥ 4-point change on 35-point International Prostate Symptom Score], acute retention, incontinence, recurrent UTI, urosepsis or renal insufficiency. Symptom progression contributed ~65% of the composite.
- Tamsulosin 22%, combination: 13%: NNT=12.
- BPH surgery:
- Tamsulosin 8%, combination 2%: NNT=23.
- Adverse effects:
- Any drug related adverse effect: Tamsulosin 19%, combination 28%; number needed to harm=12.
- Erectile dysfunction: Tamsulosin 5%, combination 9%, not statistically different.
- Dizziness: No difference.
- Clinical progression: Composite of worsening symptoms [≥ 4-point change on 35-point International Prostate Symptom Score], acute retention, incontinence, recurrent UTI, urosepsis or renal insufficiency. Symptom progression contributed ~65% of the composite.
- Clinical progression: Composite of worsening symptoms [>4 point change on 35-point American Urological Association Score], acute retention, incontinence, or recurrent urinary tract infection (UTI). Symptom progression contributed ~80% of the composite.
- 5ARI may decrease prostate cancer incidence, but cancers found may be higher grade.5,6
- 17-year follow-up: No difference in prostate cancer mortality.7
- 5ARI decreases prostate serum antigen (PSA) levels by ~50%,8 which might delay prostate cancer diagnosis.9
- If following, PSA should be multiplied by 2-2.3 for patients on 5ARI.5,6
- Canadian guidelines recommend:10
- Alpha-blockers: First line.
- Combination: If prostate enlargement.
Latest Tools for Practice
#379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy
How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
Good information. I find keeping these drugs straight a bit difficult.
the reccomendation is applicable to my practice – fell more confident in prescribing combination therapy if necessary
seems reasonable to try combo drug therapy reduce or delay need for surgery
excellent article teaching very relevant to Clinical evidance base of medicine.
excellent teaching need to present clinicla senario man age 75 BEG or ?Cancer Prostate igh PSA above 9 to 11 how long to try for above medicatiosn how we knwo it does work how to exclude we do not miss cancer of Prostate
excellent very infomrative
excellemnt